Glutathione may support a range of conditions where endogenous levels are depleted due to high oxidative stress, systemic inflammation, or immune dysregulation
Most require a BMI of 30 or higher, obesity-related conditions, and prior authorization
FDA approves oral semaglutide for type 2 diabetes, obesity indication pending The FDA has expanded oral semaglutides reach: now approved for CV risk reduction in type 2 diabetes, with an obesity indication decision expected soon
A lowering over time or oxidization of glutathione is natural
Living with Fibromyalgia
By 2050, half of all adult humans will be overweight or living with obesity, so expensive medications like GLP-1s cannot be the sole strategy for tackling the obesity crisis, which is a societal as well as a medical problem, Griffin added